“Recently I spent the afternoon with several senior executives from a large Chinese biotech company. They were all great examples of the so-called “sea turtle,” a Chinese born professional who completed their undergraduate degree in China, then left for the United States where they received both their PhD and over a decade of experience working for some of the biggest life science companies there. What brought us together was a specific question over a new innovative platform they would be bringing to market; however, we ended up spending a good bit of time discussing innovation in the life sciences in China, and what westerners many times miss when they look from the outside in at China’s various efforts to foster domestic innovation.” More available at WiCON Pharma China, here.
If you’re coming over from Health Intel Asia, welcome to Bull City Lawyer, an immigration firm founded by former Rubicon Strategy Group partner, and Health Intel Asia editor, Damjan Denoble.
While Rubicon Strategy Group LLC has closed, the full archive of its analysis on Asia’s healthcare economy can be found here on Bullcity.Lawyer.
Should you require services, please direct your inquiry to the contact us page to see if Damjan Denoble and other Bull City Lawyer attorneys may be able to help you.